Status:
RECRUITING
A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Kvalitet i Almen Praksis (KiAP)
Conditions:
Prostate Cancer
Evidence Based Medicine
Eligibility:
All Genders
Phase:
NA
Brief Summary
It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only re...
Detailed Description
Prostate cancer (PC) is the most common type of cancer among men in Denmark with an incidence of approximately 4.500 cases and 1.300 deaths every year. Usually prostate cancer develops very slowly and...
Eligibility Criteria
Inclusion Criteria:
- Quality clusters with a cluster coordinator
- Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025.
Exclusion Criteria:
- Quality clusters who already planned their cluster meetings in 2025.
- Quality clusters unwilling to await allocation before planning their cluster meetings in 2025.
- Quality clusters participating in the pilot study
Key Trial Info
Start Date :
September 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06748456
Start Date
September 9 2024
End Date
January 1 2026
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of General Practice, Department of Public Health, University of Copenhagen
Copenhagen, Denmark